Evidence map›Paper›PMID 41840065›Full record

ArticleScientific reports2026

Hybrid CNN-transformer model with BM3D and YOLOv8 for early detection of lung cancer in low-dose CT scans.

Gagan Thakral, Umesh Kumar, Sapna Gambhir

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gagan ThakralJ. C. Bose University of Science and Technology, YMCA, Faridabad, India. gagan15.thakral@gmail.com.
Umesh KumarJ. C. Bose University of Science and Technology, YMCA, Faridabad, India.
Sapna GambhirGeorge Mason University, Fairfax, VA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains the primary cause of cancer-related deaths throughout the world. The main reason behind this is late diagnosis and the restrictions in the manual interpretation of imaging data. In these days Low-Dose Computed Tomography (LDCT) has been widely adopted for early screening. LDCT contains Low Dose x-rays as compared to the normal CT scan. But the existence of noise and subtle nodular patterns often impairs diagnostic accuracy. In this study, authors proposed a novel hybrid deep learning model which uses BM3D for pre-processing and YOLOv8 for segmentation. Further this model integrates Convolutional Neural Networks (CNNs) with Transformer Encoders to enhance the early detection of lung cancer using LDCT scan images. The model powers the spatial feature extraction with the help of CNNs and the contextual reasoning capability of Transformers to achieve superior classification performance. In this work, during the training of model BM3D filtering (advanced image preprocessing technique) are applied to reduce noise and enhance structural details. Further YOLOv8 is used for segmentation. The proposed hybrid model achieved 93.8% sensitivity, 95.1% accuracy, 94.4% F1-Score, 96.2% Specificity, 0.92 Dice Metric and 0.97 AUC for classification. Experimental results demonstrate that the proposed model outperforms existing models in terms of accuracy, precision, recall, AUC, and Dice coefficient. These findings suggest that the hybrid model holds strong potential as a robust tool for early lung cancer screening and clinical decision support.

Indexed as

Early Detection of CancerLung NeoplasmsTomography, X-Ray ComputedConvolutional Neural NetworksDeep LearningHumansImage Processing, Computer-AssistedRadiation DosageCNNDeep learningEarly detectionHybrid model transformer encoderLow-dose CT scanLung cancer

Identifiers

PMID41840065
PMCPMC13121747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.